A Risk-Based Model to Establish Threshold Planning Quantities of Hazardous Substances [PDF]
, 2004 Manju Mohan, Bhola Ram Gurjar
openalex +1 more source
Cutaneous Melanoma Drives Metabolic Changes in the Aged Bone Marrow Immune Microenvironment
Aging and Cancer, EarlyView.Melanoma, the deadliest form of skin cancer, increasingly affects older adults. Our study reveals that melanoma induces changes in iron and lipid levels in the bone marrow, impacting immune cell populations and increasing susceptibility to ferroptosis.
Alexis E. Carey +12 more
wiley +1 more source
Diagnosis on Transport Risk Based on a Combined Assessment of Road Accidents and Watershed Vulnerability to Spills of Hazardous Substances. [PDF]
Int J Environ Res Public Health, 2018 Machado ER +6 more
europepmc +1 more source
Analysis of Environment Protection Act in Context of Hazardous Substances
, 2016 Jyotika Bahl
openalex +1 more source
The Aging Blood: Cellular Origins, Circulating Drivers, and Therapeutic Potential
Aging and Cancer, EarlyView.As a conduit linking all organs, the blood system both reflects and actively drives systemic aging. This review highlights how circulating pro‐aging and antiaging factors and age‐associated hematopoietic stem cell dysfunction contribute to immunosenescence and multi‐organ decline, positioning the hematopoietic system as a target for aging intervention.
Hanqing He, Jianwei Wang
wiley +1 more source
Screening analysis of RoHS directive hazardous substances (phthalate esters and bromodiphenyl ethers) by novel mass spectrometry using soft ionization. [PDF]
R Soc Open Sci, 2019 Ohgaki M +3 more
europepmc +1 more source
“The paper cups Nile”: microplastics and other hazardous substances leached from paper cups: paper cups aquatic environmental bane in the River Nile, Egypt [PDF]
Zainab Eid +2 more
openalex +1 more source
Tracking Motor Progression and Device‐Aided Therapy Eligibility in Parkinson's Disease
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To characterise the progression of motor symptoms and identify eligibility for device‐aided therapies in Parkinson's disease, using both the 5‐2‐1 criteria and a refined clinical definition, while examining differences across genetic subgroups.
David Ledingham +7 more
wiley +1 more source
Risk assessment of hazardous substances revisited. [PDF]
Ind Health, 2015 Arito H.
europepmc +1 more source